Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy
Johane M. Robitaille(Dalhousie University), Mark Samuels(Xenon Pharmaceuticals (Canada)), Marie‐Pierre Dubé(Montreal Heart Institute), Randall T. Moon(Howard Hughes Medical Institute), Ann Hoskin-Mott(Dalhousie University), Linhua Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Roshni R. Singaraja(National University of Singapore), Ajamete Kaykas(Metro Transit), Michael R. Hayden(University of British Columbia), Michael T. Trese(Beaumont Hospital, Royal Oak), Laird C. Sheldahl(University of Washington), Jutta Zeisler(Xenon Pharmaceuticals (Canada)), Simon N. Pimstone(Xenon Pharmaceuticals (Canada)), Duane L. Guernsey(Dalhousie University), Barkur S. Shastry(Oakland University), Y. Paul Goldberg(University of British Columbia), L. Siebert(Western University), Binyou Zheng(Dalhousie University), Marcia L.E. MacDonald(Xenon Pharmaceuticals (Canada))
Cited by 476
Related Papers
Huntington disease
|Nature Reviews Disease Primers|2015|1.6k
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
|Nature Medicine|2018|1k
Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
|Nature Genetics|2003|976
A viral strategy for targeting and manipulating interneurons across vertebrate species
|Nature Neuroscience|2016|584